TY - JOUR
T1 - Association between dairy product consumption and hyperuricemia in an elderly population with metabolic syndrome
AU - PREDIMED-PLUS investigators
AU - Mena-Sánchez, Guillermo
AU - Babio, Nancy
AU - Becerra-Tomás, Nerea
AU - Martínez-González, Miguel
AU - Díaz-López, Andrés
AU - Corella, Dolores
AU - Zomeño, Maria D.
AU - Romaguera, Dora
AU - Vioque, Jesús
AU - Alonso-Gómez, Ángel M.
AU - Wärnberg, Julia
AU - Martínez, José A.
AU - Serra-Majem, Luís
AU - Estruch, Ramon
AU - Bernal, Rosa
AU - Lapetra, José
AU - Pintó, Xavier
AU - Tur, Josep A.
AU - Lopez-Miranda, José
AU - Cano-Ibáñez, Naomi
AU - Gaforio, Jose J.
AU - Matía-Martín, Pilar
AU - Daimiel, Lidia
AU - Caro, José L.Llisterri
AU - Vidal, Josep
AU - Vázquez, Clotilde
AU - Ros, Emili
AU - Arellano, Ana Garcia
AU - Palau, Antoni
AU - Fernández-Carrión, Rebeca
AU - Pérez-Vega, Karla A.
AU - Morey, Marga
AU - de la Hera, Manoli García
AU - Vaquero-Luna, Jessica
AU - Carmona-González, Francisco J.
AU - Abete, Itziar
AU - Álvarez-Pérez, Jacqueline
AU - Casas, Rosa
AU - Fernández-García, José C.
AU - Santos-Lozano, José M.
AU - Corbella, Emili
AU - Sureda, Antoni
AU - Ruiz-Canela, Miguel
AU - Barragán, Rocio
AU - Goday, Albert
AU - Martín, Marian
AU - Altozano Rodado, María C.
AU - Toledo, Estefanía
AU - Fitó, Montse
AU - Salas-Salvadó, Jordi
N1 - Funding Information:
The PREDIMED-Plus trial was supported by the official funding agency for biomedical research of the Spanish government , ISCIII , through the Fondo de Investigación para la Salud (FIS) , which is co-funded by the European Regional Development Fund (four coordinated FIS projects led by J.S.-S. and J.V., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, and PI17/00926), the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to J.S.-S., the European Research Council (Advanced Research Grant 2013–2018, 340918) to M.Á.M.-G., the Recercaixa grant to J.S.-S (2013ACUP00194), grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, and PI0137/2018), a grant from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN grant, and funds from the European Regional Development Fund ( CB06/03 ).
Funding Information:
The PREDIMED-Plus trial was supported by the official funding agency for biomedical research of the Spanish government, ISCIII, through the Fondo de Investigaci?n para la Salud (FIS), which is co-funded by the European Regional Development Fund (four coordinated FIS projects led by J.S.-S. and J.V., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, and PI17/00926), the Especial Action Project entitled: Implementaci?n y evaluaci?n de una intervenci?n intensiva sobre la actividad f?sica Cohorte PREDIMED-Plus grant to J.S.-S., the European Research Council (Advanced Research Grant 2013?2018, 340918) to M.?.M.-G., the Recercaixa grant to J.S.-S (2013ACUP00194), grants from the Consejer?a de Salud de la Junta de Andaluc?a (PI0458/2013, PS0358/2016, and PI0137/2018), a grant from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN grant, and funds from the European Regional Development Fund (CB06/03).Salas-Salvad? J reports that he has served on the Board of and received grant support through his institution from the International Nut and Dried Fruit Council; has served as a member of the Danone S.A. Advisory Board; has received personal consulting fees from Danone, Font Vella Lanjaron, Nuts for Life, and Eroski; and has received grant support through his institution from the Nut and Dried Fruit Foundation and Eroski.
Publisher Copyright:
© 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University
PY - 2020/2/10
Y1 - 2020/2/10
N2 - Background and aims: The prevalence of hyperuricemia has increased substantially in recent decades. It has been suggested that it is an independent risk factor for weight gain, hypertension, hypertriglyceridemia, metabolic syndrome (MetS), and cardiovascular disease. Results from epidemiological studies conducted in different study populations have suggested that high consumption of dairy products is associated with a lower risk of developing hyperuricemia. However, this association is still unclear. The aim of the present study is to explore the association of the consumption of total dairy products and their subtypes with the risk of hyperuricemia in an elderly Mediterranean population with MetS. Methods and results: Baseline cross-sectional analyses were conducted on 6329 men/women (mean age 65 years) with overweight/obesity and MetS from the PREDIMED-Plus cohort. Dairy consumption was assessed using a food frequency questionnaire. Multivariable-adjusted Cox regressions were fitted to analyze the association of quartiles of consumption of total dairy products and their subtypes with the prevalence of hyperuricemia. Participants in the upper quartile of the consumption of total dairy products (multiadjusted prevalence ratio (PR) = 0.84; 95% CI: 0.75–0.94; P-trend 0.02), low-fat dairy products (PR = 0.79; 95% CI: 0.70–0.89; P-trend <0.001), total milk (PR = 0.81; 95% CI: 0.73–0.90; P-trend<0.001), low-fat milk (PR = 0.80; 95% CI: 0.72–0.89; P-trend<0.001, respectively), low-fat yogurt (PR = 0.89; 95% CI: 0.80–0.98; P-trend 0.051), and cheese (PR = 0.86; 95% CI: 0.77–0.96; P-trend 0.003) presented a lower prevalence of hyperuricemia. Whole-fat dairy, fermented dairy, and yogurt consumption were not associated with hyperuricemia. Conclusions: High consumption of total dairy products, total milk, low-fat dairy products, low-fat milk, low-fat yogurt, and cheese is associated with a lower risk of hyperuricemia.
AB - Background and aims: The prevalence of hyperuricemia has increased substantially in recent decades. It has been suggested that it is an independent risk factor for weight gain, hypertension, hypertriglyceridemia, metabolic syndrome (MetS), and cardiovascular disease. Results from epidemiological studies conducted in different study populations have suggested that high consumption of dairy products is associated with a lower risk of developing hyperuricemia. However, this association is still unclear. The aim of the present study is to explore the association of the consumption of total dairy products and their subtypes with the risk of hyperuricemia in an elderly Mediterranean population with MetS. Methods and results: Baseline cross-sectional analyses were conducted on 6329 men/women (mean age 65 years) with overweight/obesity and MetS from the PREDIMED-Plus cohort. Dairy consumption was assessed using a food frequency questionnaire. Multivariable-adjusted Cox regressions were fitted to analyze the association of quartiles of consumption of total dairy products and their subtypes with the prevalence of hyperuricemia. Participants in the upper quartile of the consumption of total dairy products (multiadjusted prevalence ratio (PR) = 0.84; 95% CI: 0.75–0.94; P-trend 0.02), low-fat dairy products (PR = 0.79; 95% CI: 0.70–0.89; P-trend <0.001), total milk (PR = 0.81; 95% CI: 0.73–0.90; P-trend<0.001), low-fat milk (PR = 0.80; 95% CI: 0.72–0.89; P-trend<0.001, respectively), low-fat yogurt (PR = 0.89; 95% CI: 0.80–0.98; P-trend 0.051), and cheese (PR = 0.86; 95% CI: 0.77–0.96; P-trend 0.003) presented a lower prevalence of hyperuricemia. Whole-fat dairy, fermented dairy, and yogurt consumption were not associated with hyperuricemia. Conclusions: High consumption of total dairy products, total milk, low-fat dairy products, low-fat milk, low-fat yogurt, and cheese is associated with a lower risk of hyperuricemia.
KW - Cheese
KW - Dairy products
KW - Hyperuricemia
KW - Milk
KW - Yogurt
UR - http://www.scopus.com/inward/record.url?scp=85075861285&partnerID=8YFLogxK
U2 - 10.1016/j.numecd.2019.09.023
DO - 10.1016/j.numecd.2019.09.023
M3 - Article
C2 - 31791636
AN - SCOPUS:85075861285
SN - 0939-4753
VL - 30
SP - 214
EP - 222
JO - Nutrition, Metabolism and Cardiovascular Diseases
JF - Nutrition, Metabolism and Cardiovascular Diseases
IS - 2
ER -